Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...
At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery ...
RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the ...
Medtronic and Zimmer Biomet were named on the 2025 “World’s Most Ethical” list. The list recognizes 136 organizations for “for their unwavering commitment to business integrity.” Ethisphere, which ...
"Concerns arise over GLP-1 use during major surgeries like joint replacements. A study reveals optimal timing for stopping Ozempic to reduce anesthesia risks." ...
The Terminator actor teamed up with Zimmer Biomet to raise awareness about osteoarthritis, which affects more than 25 million ...
Medical Device Network on MSN1d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...
Zimmer Biomet Holdings, Inc. , a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTiontm Femur, a revision knee ...
The Smart Orthopedic Implants market is expected to grow from an estimated USD 26.21 Billion in 2024 to USD 40.66 Billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback